ApoA1 Trial Misses Endpoint, But HDL Hypothesis Still Alive? ...Middle East

ApoA1 infusions in acute MI did not significantly reduce the composite endpoint in the AEGIS-II trial. However, an exploratory analysis suggested benefit at higher LDL levels. Medscape Medical News

Hence then, the article about apoa1 trial misses endpoint but hdl hypothesis still alive was published today ( Sunday 07/04/2024 - 12:01 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ApoA1 Trial Misses Endpoint, But HDL Hypothesis Still Alive? )

Also on site :

• Firefighters rush to Morrisons convenience store in Oswestry after report of fire
• Today's Famous Celebrity Birthdays for March 22, 2026: Reese Witherspoon, William Shatner
• Iranian Revolutionary Guard: 200 Killed and Wounded Among Zionist Enemy in 73rd Wave